SCHEMBL184333

SCHEMBL184333

Cc1ccc2c(N3CC[C@@H](N(CC(C)C)C(=O)O)C3)nc(-c3ccccc3C(F)F)nc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 4/20 0.45
MAPT P10636 3/20 0.37
CYP1A2 P05177 5/20 0.35
TSHR P16473 4/20 0.35
CYP3A4 P08684 4/20 0.35
CYP2D6 P10635 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CLK4 Q9HAZ1 3/20 0.34
USP2 O75604 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPK1 P28482 2/20 0.34
CYP2C9 P11712 1/20 0.34
ALOX15 P16050 1/20 0.34
CYP2C19 P33261 1/20 0.34
CASP7 P55210 1/20 0.34
RORC P51449 2/20 0.34
HIF1A Q16665 1/20 0.34
KDM4E B2RXH2 2/20 0.34
TP53 P04637 1/20 0.34
JAK2 O60674 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL184335 1.00 CHEK2 (0.45) CHEK2MAPTCYP1A2TSHRCYP3A4
SCHEMBL238371 0.90 CHEK2 (0.58) CHEK2MAPTCYP1A2TSHRCYP3A4
SCHEMBL238373 0.90 CHEK2 (0.58) CHEK2MAPTCYP1A2TSHRCYP3A4
SCHEMBL183850 0.81 CHEK2 (0.42) CHEK2MAPTCYP1A2TSHRCYP3A4
SCHEMBL1621663 0.80 CHEK2 (0.60) CHEK2MAPTCYP1A2TSHRCYP3A4
Hydrochloric Acid SCHEMBL1624310 0.79 CHEK2 (0.59) CHEK2MAPTCYP1A2TSHRCYP3A4
SCHEMBL14535451 0.79 MAPT (0.42) CHEK2MAPTCYP1A2TSHRCYP3A4
SCHEMBL183832 0.79 PDE10A (0.39) CHEK2MAPTHIF1AKDM4ETP53
SCHEMBL183833 0.79 PDE10A (0.39) CHEK2MAPTHIF1AKDM4ETP53
SCHEMBL239804 0.78 CHEK2 (0.59) CHEK2MAPTTSHRALDH1A1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957482-B1 QUINAZOLINES USEFUL AS MODULATORS OF VOLTAGE GATED ION CHANNELS VERTEX PHARMA (US) 2012-01-04 EP disclosed